The QMN Weekly Bulletin
Pharmaceuticals / Regulatory Affairs

Health Canada Looks to Speed Up Recall Actions, Industry Notification

Nov. 22, 2013
A A
After assessing its response to a recall in April, Health Canada is considering requiring drugmakers to notify the agency about emerging risks of marketed drugs before initiating recalls. Doing so would ensure that the agency is fully engaged in a company’s risk assessment and help it determine the most appropriate action, a new report says. Currently, drugmakers must notify Health Canada within 24 hours of making a decision to recall a drug.
International Pharmaceutical Regulatory Monitor